发明名称 HDEG technology
摘要 A method of producing an extruded, powdered/granulated composition comprising an active pharmaceutical ingredient (API) is provided wherein the method comprises the steps of: (a) providing an API; (b) providing a porous and particulate inorganic excipient; and (c) processing (a) and (b) by a twin screw granulation process to directly produce an extruded, powdered/granulated composition wherein the API is absorbed within the pores of the carrier particles. Preferably the inorganic excipient is a metal aluminasilicate, in particular magnesium alumino-metasilicate (Al2O3.MgO.1.7SiO2.xH2O). The method may further include the steps of (d) blending the extruded, powdered/granulated composition with one or more pharmaceutically acceptable excipients to produce a composition blend; and (e) directly compressing the composition blend into a direct compression tablet. The API is preferably ibuprofen or indomethacin. Preferably the API is melted or solubilised in a solubiliser. A powdered/granulated composition comprising an API absorbed within the pores of a porous and particulate inorganic excipients is also outlined.
申请公布号 GB201502073(D0) 申请公布日期 2015.03.25
申请号 GB20150002073 申请日期 2015.02.09
申请人 CUBIC PHARMACEUTICALS LIMITED AND DELTA PHARMACEUTICALS LIMITED 发明人
分类号 主分类号
代理机构 代理人
主权项
地址